Biotech

All Articles

Rivus' phase 2 obesity-related heart failure test attacks endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its fat-busting, muscle-sparing medi...

Ovid stops preclinical job, IV plan after soticlestat fall short

.Ovid Rehab already disclosed final month that it was trimming back its head count as the company ge...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has opened up a $700 thousand R&ampD center in the Boston ma Seaport, increasing its own ...

Boundless Biography produces 'moderate' unemployments five months after $100M IPO

.Just 5 months after securing a $one hundred million IPO, Limitless Bio is actually presently giving...

Halda's $126M is going to advance 'hold as well as get rid of' growth medications

.The first stages of oncology R&ampD may not be short of appealing brand-new techniques, and Halda T...

Lykos 'regrets' not making known study offenses along with author

.Psychopharmacology has actually drawn 3 short articles concerning midstage scientific trial records...

Analysts dig into Avidity's DMD win, exposing nuances in data

.Avidity Biosciences satisfied clients along with phase 1/2 data in Duchenne muscular dystrophy (DMD...

Actinogen's cortisol blocker neglects stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually overlooked the key endpoint of a period 2 study i...

Bivictrix makes a decision going private only way to take ADC into facility

.Antibody-drug conjugates (ADCs) have actually been at the facility of many a billion-dollar biobuck...

TPG tops up funds to $580M for assets all over lifestyle scientific researches

.Asset manager TPG, which has assisted biotechs like Sionna Therapeutics as well as Santa Clam Ana B...